Pronova BioPharma ASA: Pronova BioPharma has published its Annual Report 2011
(Thomson Reuters ONE) -
29 March 2012, Lysaker, Norway: Pronova BioPharma's Annual Report 2011 documents
that the Company continued to generate strong cash flow in 2011 and made
significant progress towards its strategic objectives.
The core pharmaceutical business continued to grow, and the Company launched its
product in new markets.
On the manufacturing side, yield was improved to further strengthen the
competitive advantage in manufacturing versus potential market entrants.
With the progress in R&D, expansion into clinical nutrition and plans to launch
a consumer healthcare business, Pronova BioPharma also became a more diversified
Company with new sources of future growth.
Pronova BioPharma's annual financial accounts 2011 have been approved by the
Board of Directors.
The entire Annual Report has been published on www.pronova.com and can be
downloaded as a pdf document.
The Annual Report will also be available in printed version from mid April
2012. Printed versions can be ordered by interested parties via ir(at)pronova.com
Contacts:
Pronova BioPharma ASA
Hamed Brodersen
VP Investor Relations and Communications
Tel: +47 40 46 81 10
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Pronova BioPharma Annual Report 2011:
http://hugin.info/137506/R/1598372/503993.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
[HUG#1598372]
Unternehmensinformation / Kurzprofil:
Datum: 29.03.2012 - 14:03 Uhr
Sprache: Deutsch
News-ID 129954
Anzahl Zeichen: 2110
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 285 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pronova BioPharma ASA: Pronova BioPharma has published its Annual Report 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
